Greenidge Generation Holdings Inc. (GREE): Nasdaq/NYSE listing notice — Greenidge receives Nasdaq delisting notice for failing $15M public float requirement

Greenidge Generation Holdings Inc.

Received Nasdaq notice on June 15, 2023 for failing to maintain minimum $15M Market Value of Publicly Held Shares for 30 consecutive days.
Cure period ends December 12, 2023; compliance requires MVPHS at or above $15M for 10 consecutive business days.
Common stock remains listed on Nasdaq Global Select during the 180-day cure period.
Company exploring alternatives to regain compliance; failure may lead to delisting.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.97

Greenidge Generation Holdings Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(3)(C), 5810(c)(3)(D)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5450(b)(3)(C), 5810(c)(3)(D)

Exact text from the filing

June 15, 2023, Greenidge Generation Holdings Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company failed to maintain a minimum Market Value of Publicly Held Shares of $15 million for the prior 30 consecutive trading day period, as set forth in Nasdaq Listing Rule 5450(b)(3)(C) (the “MVPHS Requirement”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(D), the Company has a compliance period of 180 calendar days, or until December 12, 2023, to regain compliance with the MVPHS Require

View on SEC.gov

Browse all listing & compliance notices →

Greenidge Generation Holdings Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-022465

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.